Cargando…
Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
AIM: This study aimed to explore the mechanism of LncRNA urothelial carcinoma-associated 1 (UCA1) promoting cisplatin resistance in lung adenocarcinoma (LUAD). METHOD: The UCA1 expression level in LUAD cell lines was detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR)....
Autores principales: | Fu, Jiali, Pan, Jingjing, Yang, Xiang, Zhang, Yan, Shao, Fanggui, Chen, Jie, Huang, Kate, Wang, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454127/ https://www.ncbi.nlm.nih.gov/pubmed/34544452 http://dx.doi.org/10.1186/s12935-021-02207-0 |
Ejemplares similares
-
Analysis of lncRNA UCA1‐related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma
por: Zhou, Huixin, et al.
Publicado: (2020) -
LncRNA UCA1 facilitated cell growth and invasion through the miR-206/CLOCK axis in glioma
por: Huang, Zhi, et al.
Publicado: (2019) -
Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
por: Yao, Jie, et al.
Publicado: (2021) -
Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p
por: Hu, Minhua, et al.
Publicado: (2020) -
lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2020)